 Vikhyat Bebarta
Concepts (594)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antidotes | 34 | 2023 | 126 | 13.000 |
Why?
| | Military Personnel | 48 | 2023 | 529 | 10.260 |
Why?
| | Cyanides | 25 | 2023 | 46 | 8.080 |
Why?
| | Hydroxocobalamin | 17 | 2020 | 26 | 7.570 |
Why?
| | Wounds and Injuries | 33 | 2023 | 772 | 6.830 |
Why?
| | Emergency Medical Services | 31 | 2023 | 589 | 6.690 |
Why?
| | Air Ambulances | 14 | 2022 | 32 | 4.500 |
Why?
| | Resuscitation | 13 | 2023 | 253 | 3.990 |
Why?
| | Cobamides | 8 | 2022 | 18 | 3.930 |
Why?
| | Afghan Campaign 2001- | 29 | 2023 | 161 | 3.830 |
Why?
| | Swine | 34 | 2023 | 730 | 3.790 |
Why?
| | Military Medicine | 15 | 2022 | 94 | 3.730 |
Why?
| | Thiosulfates | 8 | 2021 | 19 | 3.460 |
Why?
| | Hydrogen Sulfide | 7 | 2022 | 40 | 3.230 |
Why?
| | Potassium Cyanide | 8 | 2021 | 18 | 3.090 |
Why?
| | Poisoning | 9 | 2023 | 109 | 2.790 |
Why?
| | Infusions, Intraosseous | 9 | 2022 | 19 | 2.690 |
Why?
| | Hypotension | 11 | 2021 | 120 | 2.640 |
Why?
| | Warfare | 12 | 2023 | 77 | 2.540 |
Why?
| | Critical Care | 11 | 2023 | 492 | 2.540 |
Why?
| | Apnea | 5 | 2020 | 16 | 2.520 |
Why?
| | Hospitals, Military | 9 | 2018 | 34 | 2.430 |
Why?
| | Emergency Medicine | 10 | 2018 | 238 | 2.300 |
Why?
| | Analgesics, Opioid | 15 | 2020 | 793 | 2.200 |
Why?
| | Hydrocodone | 5 | 2019 | 15 | 2.180 |
Why?
| | Airway Management | 5 | 2019 | 63 | 2.180 |
Why?
| | Heart Arrest | 7 | 2020 | 291 | 2.170 |
Why?
| | Emergency Service, Hospital | 15 | 2019 | 1864 | 2.060 |
Why?
| | Iraq War, 2003-2011 | 18 | 2023 | 151 | 1.980 |
Why?
| | Disease Models, Animal | 27 | 2023 | 3730 | 1.950 |
Why?
| | Sulfides | 7 | 2022 | 96 | 1.840 |
Why?
| | Antidepressive Agents, Tricyclic | 6 | 2014 | 29 | 1.720 |
Why?
| | Transportation of Patients | 3 | 2018 | 49 | 1.720 |
Why?
| | Afghanistan | 15 | 2023 | 108 | 1.690 |
Why?
| | Mass Casualty Incidents | 7 | 2022 | 38 | 1.640 |
Why?
| | Analgesics | 4 | 2017 | 159 | 1.620 |
Why?
| | Brain Injuries, Traumatic | 6 | 2023 | 318 | 1.620 |
Why?
| | Humans | 157 | 2023 | 118983 | 1.560 |
Why?
| | Critical Illness | 10 | 2023 | 663 | 1.540 |
Why?
| | Injury Severity Score | 15 | 2022 | 528 | 1.460 |
Why?
| | Cardiopulmonary Resuscitation | 5 | 2020 | 225 | 1.440 |
Why?
| | Sulfhydryl Compounds | 5 | 2022 | 179 | 1.440 |
Why?
| | Ketamine | 5 | 2020 | 93 | 1.430 |
Why?
| | Airway Obstruction | 3 | 2018 | 168 | 1.400 |
Why?
| | Retrospective Studies | 42 | 2023 | 12977 | 1.400 |
Why?
| | Heart Massage | 3 | 2019 | 7 | 1.390 |
Why?
| | Female | 86 | 2023 | 61574 | 1.380 |
Why?
| | Shock, Hemorrhagic | 5 | 2023 | 206 | 1.380 |
Why?
| | Toxicology | 4 | 2018 | 35 | 1.370 |
Why?
| | Male | 89 | 2023 | 57808 | 1.360 |
Why?
| | Research | 6 | 2022 | 411 | 1.360 |
Why?
| | Drug Overdose | 10 | 2016 | 294 | 1.320 |
Why?
| | Pressure | 2 | 2020 | 226 | 1.300 |
Why?
| | Animals | 59 | 2023 | 33390 | 1.300 |
Why?
| | Patient Transfer | 3 | 2019 | 143 | 1.290 |
Why?
| | Poison Control Centers | 8 | 2017 | 84 | 1.290 |
Why?
| | Intubation, Intratracheal | 8 | 2023 | 226 | 1.250 |
Why?
| | Respiration, Artificial | 6 | 2023 | 545 | 1.230 |
Why?
| | Brugada Syndrome | 4 | 2008 | 10 | 1.220 |
Why?
| | Opioid-Related Disorders | 7 | 2019 | 417 | 1.220 |
Why?
| | Adult | 60 | 2023 | 31515 | 1.220 |
Why?
| | Registries | 17 | 2023 | 1810 | 1.200 |
Why?
| | Amitriptyline | 4 | 2011 | 21 | 1.160 |
Why?
| | Prospective Studies | 26 | 2023 | 6473 | 1.140 |
Why?
| | Sodium Nitrite | 4 | 2016 | 36 | 1.120 |
Why?
| | United States | 39 | 2023 | 12554 | 1.100 |
Why?
| | Pain Measurement | 3 | 2018 | 469 | 1.090 |
Why?
| | Random Allocation | 7 | 2020 | 344 | 1.090 |
Why?
| | Sodium Bicarbonate | 6 | 2016 | 45 | 1.080 |
Why?
| | Hydrogen Cyanide | 3 | 2022 | 5 | 1.070 |
Why?
| | Craniocerebral Trauma | 2 | 2020 | 146 | 1.060 |
Why?
| | Substance Abuse Detection | 4 | 2019 | 63 | 1.060 |
Why?
| | Hydromorphone | 3 | 2016 | 7 | 1.040 |
Why?
| | Hemodynamics | 11 | 2023 | 1004 | 1.030 |
Why?
| | Wounds, Penetrating | 3 | 2023 | 77 | 1.020 |
Why?
| | Pain Management | 4 | 2020 | 293 | 1.020 |
Why?
| | Injections, Intramuscular | 6 | 2020 | 116 | 1.000 |
Why?
| | Hemorrhage | 8 | 2023 | 623 | 1.000 |
Why?
| | Blood Transfusion | 7 | 2023 | 306 | 0.990 |
Why?
| | Acute Pain | 2 | 2015 | 33 | 0.980 |
Why?
| | Remote Consultation | 2 | 2015 | 39 | 0.980 |
Why?
| | Heart Ventricles | 3 | 2020 | 727 | 0.980 |
Why?
| | War-Related Injuries | 3 | 2021 | 33 | 0.970 |
Why?
| | Wounds, Gunshot | 3 | 2022 | 176 | 0.970 |
Why?
| | Blood Pressure | 10 | 2018 | 1664 | 0.930 |
Why?
| | Chromatography, Liquid | 4 | 2022 | 355 | 0.920 |
Why?
| | Environmental Exposure | 4 | 2019 | 405 | 0.910 |
Why?
| | Tandem Mass Spectrometry | 5 | 2022 | 421 | 0.910 |
Why?
| | Tetrathionic Acid | 2 | 2021 | 4 | 0.900 |
Why?
| | Snake Bites | 5 | 2019 | 53 | 0.900 |
Why?
| | Sus scrofa | 7 | 2020 | 48 | 0.900 |
Why?
| | Time Factors | 14 | 2020 | 6414 | 0.870 |
Why?
| | Laryngoscopy | 4 | 2023 | 97 | 0.870 |
Why?
| | Internship and Residency | 4 | 2016 | 1001 | 0.860 |
Why?
| | Young Adult | 28 | 2021 | 10795 | 0.840 |
Why?
| | Compartment Syndromes | 1 | 2022 | 38 | 0.810 |
Why?
| | Acetylcysteine | 2 | 2014 | 148 | 0.800 |
Why?
| | Administration, Intravenous | 5 | 2019 | 136 | 0.790 |
Why?
| | Saline Solution, Hypertonic | 2 | 2014 | 56 | 0.790 |
Why?
| | Laryngoscopes | 3 | 2023 | 38 | 0.780 |
Why?
| | Acetaminophen | 3 | 2014 | 244 | 0.760 |
Why?
| | Firearms | 3 | 2022 | 281 | 0.760 |
Why?
| | Pain | 5 | 2018 | 735 | 0.760 |
Why?
| | Iraq | 8 | 2023 | 82 | 0.750 |
Why?
| | Patient Handoff | 1 | 2020 | 27 | 0.750 |
Why?
| | Burns | 4 | 2017 | 247 | 0.750 |
Why?
| | Cannabinoids | 2 | 2012 | 115 | 0.750 |
Why?
| | Morphine | 3 | 2017 | 134 | 0.740 |
Why?
| | Epinephrine | 5 | 2022 | 167 | 0.740 |
Why?
| | Thorax | 1 | 2020 | 45 | 0.740 |
Why?
| | Thiadiazoles | 1 | 2020 | 21 | 0.730 |
Why?
| | Balloon Occlusion | 1 | 2020 | 26 | 0.730 |
Why?
| | Administration, Oral | 6 | 2021 | 756 | 0.710 |
Why?
| | Chemically-Induced Disorders | 1 | 2019 | 2 | 0.700 |
Why?
| | Infusions, Intravenous | 8 | 2020 | 380 | 0.700 |
Why?
| | Trauma Centers | 4 | 2020 | 388 | 0.700 |
Why?
| | Antivenins | 4 | 2013 | 54 | 0.680 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2018 | 7 | 0.680 |
Why?
| | Blast Injuries | 5 | 2021 | 42 | 0.680 |
Why?
| | Nursing Care | 1 | 2018 | 30 | 0.650 |
Why?
| | Glycine | 1 | 2019 | 162 | 0.650 |
Why?
| | Humerus | 3 | 2022 | 44 | 0.650 |
Why?
| | Amputation, Traumatic | 1 | 2018 | 18 | 0.650 |
Why?
| | Ventricular Fibrillation | 1 | 2018 | 51 | 0.640 |
Why?
| | Norepinephrine | 1 | 2019 | 212 | 0.640 |
Why?
| | Preceptorship | 1 | 2018 | 63 | 0.640 |
Why?
| | Chronic Pain | 3 | 2020 | 211 | 0.640 |
Why?
| | Cricoid Cartilage | 2 | 2015 | 17 | 0.640 |
Why?
| | Military Facilities | 1 | 2017 | 2 | 0.630 |
Why?
| | Emergency Treatment | 4 | 2018 | 110 | 0.630 |
Why?
| | Fellowships and Scholarships | 3 | 2016 | 250 | 0.630 |
Why?
| | Tablets | 1 | 2017 | 35 | 0.630 |
Why?
| | Hypocalcemia | 3 | 2023 | 31 | 0.620 |
Why?
| | Aorta | 1 | 2020 | 367 | 0.620 |
Why?
| | Cardiovascular Agents | 1 | 2019 | 126 | 0.620 |
Why?
| | Monitoring, Physiologic | 7 | 2021 | 272 | 0.620 |
Why?
| | Hyperoxia | 4 | 2023 | 97 | 0.610 |
Why?
| | Evidence-Based Emergency Medicine | 2 | 2016 | 4 | 0.600 |
Why?
| | Treatment Outcome | 16 | 2023 | 9343 | 0.590 |
Why?
| | Oseltamivir | 1 | 2016 | 11 | 0.570 |
Why?
| | Abdominal Pain | 2 | 2019 | 133 | 0.570 |
Why?
| | Gas Poisoning | 1 | 2016 | 5 | 0.570 |
Why?
| | Altitude | 1 | 2020 | 422 | 0.570 |
Why?
| | Tourniquets | 3 | 2021 | 27 | 0.570 |
Why?
| | Smoke Inhalation Injury | 1 | 2016 | 19 | 0.570 |
Why?
| | Telemedicine | 2 | 2015 | 664 | 0.560 |
Why?
| | Emergency Medical Technicians | 1 | 2016 | 39 | 0.560 |
Why?
| | Substance-Related Disorders | 4 | 2017 | 971 | 0.550 |
Why?
| | Adolescent | 25 | 2021 | 18479 | 0.550 |
Why?
| | Out-of-Hospital Cardiac Arrest | 1 | 2016 | 79 | 0.540 |
Why?
| | Tibia | 2 | 2014 | 177 | 0.530 |
Why?
| | Acidosis, Lactic | 1 | 2015 | 29 | 0.530 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 870 | 0.530 |
Why?
| | Hematinics | 1 | 2015 | 17 | 0.520 |
Why?
| | Asphyxia | 1 | 2014 | 22 | 0.510 |
Why?
| | Electrocardiography | 5 | 2012 | 556 | 0.510 |
Why?
| | Diphenhydramine | 2 | 2015 | 29 | 0.510 |
Why?
| | Patient Simulation | 1 | 2014 | 30 | 0.500 |
Why?
| | Self Report | 2 | 2017 | 699 | 0.500 |
Why?
| | Efficiency | 1 | 2015 | 89 | 0.490 |
Why?
| | Awards and Prizes | 1 | 2015 | 57 | 0.490 |
Why?
| | Middle Aged | 28 | 2021 | 27623 | 0.480 |
Why?
| | Anemia | 1 | 2015 | 146 | 0.480 |
Why?
| | Tracheotomy | 1 | 2014 | 21 | 0.480 |
Why?
| | Solvents | 2 | 2004 | 118 | 0.480 |
Why?
| | Exsanguination | 1 | 2013 | 16 | 0.480 |
Why?
| | Dietary Supplements | 1 | 2017 | 467 | 0.470 |
Why?
| | Tracheostomy | 1 | 2015 | 102 | 0.470 |
Why?
| | Texas | 5 | 2017 | 186 | 0.470 |
Why?
| | Practice Patterns, Physicians' | 3 | 2020 | 1199 | 0.460 |
Why?
| | Incidence | 10 | 2022 | 2424 | 0.450 |
Why?
| | Superior Mesenteric Artery Syndrome | 1 | 2013 | 7 | 0.450 |
Why?
| | Mobile Health Units | 2 | 2012 | 16 | 0.450 |
Why?
| | Seizures | 3 | 2013 | 345 | 0.450 |
Why?
| | Glyoxylates | 2 | 2023 | 9 | 0.440 |
Why?
| | Forensic Medicine | 1 | 2012 | 16 | 0.440 |
Why?
| | Aerospace Medicine | 3 | 2017 | 20 | 0.440 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2014 | 136 | 0.440 |
Why?
| | Methanol | 2 | 2016 | 35 | 0.430 |
Why?
| | Viperidae | 2 | 2011 | 11 | 0.430 |
Why?
| | Mass Screening | 2 | 2018 | 1052 | 0.430 |
Why?
| | Chi-Square Distribution | 4 | 2019 | 525 | 0.420 |
Why?
| | Referral and Consultation | 1 | 2016 | 648 | 0.410 |
Why?
| | Hyperalgesia | 1 | 2012 | 108 | 0.410 |
Why?
| | Vitamin B 12 | 1 | 2012 | 115 | 0.410 |
Why?
| | Metformin | 1 | 2015 | 295 | 0.410 |
Why?
| | Renal Dialysis | 1 | 2015 | 378 | 0.410 |
Why?
| | Fires | 1 | 2012 | 75 | 0.400 |
Why?
| | Education, Medical | 1 | 2014 | 239 | 0.400 |
Why?
| | Gait | 1 | 2014 | 253 | 0.400 |
Why?
| | Gas Chromatography-Mass Spectrometry | 3 | 2020 | 135 | 0.400 |
Why?
| | Bone and Bones | 1 | 2014 | 289 | 0.400 |
Why?
| | Fluid Therapy | 3 | 2019 | 131 | 0.400 |
Why?
| | Injections, Intravenous | 5 | 2018 | 210 | 0.390 |
Why?
| | Survival Rate | 6 | 2018 | 1720 | 0.390 |
Why?
| | Extremities | 2 | 2022 | 113 | 0.390 |
Why?
| | Antiviral Agents | 1 | 2016 | 654 | 0.380 |
Why?
| | Waiting Lists | 1 | 2012 | 228 | 0.380 |
Why?
| | Lung | 2 | 2020 | 3664 | 0.380 |
Why?
| | Influenza, Human | 1 | 2016 | 554 | 0.380 |
Why?
| | Medical Records | 2 | 2021 | 163 | 0.370 |
Why?
| | Prescription Drug Misuse | 4 | 2020 | 38 | 0.340 |
Why?
| | Survival Analysis | 4 | 2021 | 1267 | 0.330 |
Why?
| | Guideline Adherence | 4 | 2023 | 523 | 0.330 |
Why?
| | Immunoglobulin Fragments | 1 | 2008 | 15 | 0.330 |
Why?
| | Omeprazole | 1 | 2008 | 5 | 0.330 |
Why?
| | Vascular Resistance | 3 | 2015 | 356 | 0.320 |
Why?
| | Tranexamic Acid | 2 | 2023 | 37 | 0.320 |
Why?
| | Rhabdomyolysis | 1 | 2008 | 18 | 0.320 |
Why?
| | Antifibrinolytic Agents | 2 | 2023 | 44 | 0.320 |
Why?
| | Hydrothorax | 1 | 2007 | 3 | 0.320 |
Why?
| | Coma | 2 | 2022 | 32 | 0.320 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1185 | 0.310 |
Why?
| | Hyponatremia | 1 | 2008 | 42 | 0.310 |
Why?
| | South Africa | 3 | 2023 | 163 | 0.310 |
Why?
| | Immunoglobulin Fab Fragments | 2 | 2008 | 69 | 0.310 |
Why?
| | Oxygen | 3 | 2021 | 854 | 0.310 |
Why?
| | Drug Therapy, Combination | 4 | 2019 | 965 | 0.310 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 1035 | 0.310 |
Why?
| | Physicians | 5 | 2019 | 793 | 0.310 |
Why?
| | Delirium | 1 | 2008 | 70 | 0.300 |
Why?
| | Infant | 10 | 2021 | 8293 | 0.300 |
Why?
| | Proton Pump Inhibitors | 1 | 2008 | 98 | 0.300 |
Why?
| | Practice Guidelines as Topic | 2 | 2017 | 1440 | 0.300 |
Why?
| | Psoas Abscess | 1 | 2006 | 2 | 0.300 |
Why?
| | Thiocyanates | 4 | 2016 | 29 | 0.300 |
Why?
| | Methicillin Resistance | 1 | 2006 | 19 | 0.290 |
Why?
| | Formates | 1 | 2006 | 13 | 0.290 |
Why?
| | Child, Preschool | 10 | 2021 | 9491 | 0.290 |
Why?
| | Linear Models | 3 | 2015 | 827 | 0.290 |
Why?
| | Cohort Studies | 6 | 2023 | 5115 | 0.290 |
Why?
| | Explosions | 2 | 2021 | 10 | 0.290 |
Why?
| | Blindness | 1 | 2006 | 35 | 0.280 |
Why?
| | Poisons | 2 | 2019 | 21 | 0.280 |
Why?
| | Fentanyl | 2 | 2017 | 70 | 0.280 |
Why?
| | Zebrafish | 2 | 2022 | 437 | 0.280 |
Why?
| | Toxicity Tests, Acute | 2 | 2018 | 10 | 0.280 |
Why?
| | Tertiary Care Centers | 2 | 2017 | 119 | 0.280 |
Why?
| | Kaplan-Meier Estimate | 2 | 2018 | 842 | 0.280 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2019 | 124 | 0.280 |
Why?
| | Intention | 1 | 2007 | 142 | 0.280 |
Why?
| | Rabbits | 5 | 2021 | 780 | 0.270 |
Why?
| | Hospitals | 2 | 2022 | 597 | 0.270 |
Why?
| | Psychotropic Drugs | 1 | 2005 | 58 | 0.270 |
Why?
| | Travel | 2 | 2016 | 116 | 0.260 |
Why?
| | Cannabis | 1 | 2012 | 382 | 0.260 |
Why?
| | Double-Blind Method | 2 | 2015 | 1687 | 0.260 |
Why?
| | Crotalid Venoms | 2 | 2011 | 31 | 0.260 |
Why?
| | Fat Emulsions, Intravenous | 2 | 2015 | 31 | 0.260 |
Why?
| | Cocaine | 1 | 2007 | 158 | 0.260 |
Why?
| | Suicide, Attempted | 4 | 2015 | 316 | 0.260 |
Why?
| | Echocardiography | 2 | 2018 | 556 | 0.250 |
Why?
| | Diagnosis, Differential | 4 | 2015 | 1384 | 0.250 |
Why?
| | Surveys and Questionnaires | 8 | 2017 | 4708 | 0.250 |
Why?
| | Child | 15 | 2021 | 19129 | 0.250 |
Why?
| | Terpenes | 1 | 2004 | 23 | 0.250 |
Why?
| | Hydrocarbons | 1 | 2004 | 34 | 0.250 |
Why?
| | Research Design | 3 | 2015 | 969 | 0.250 |
Why?
| | Pilot Projects | 4 | 2023 | 1419 | 0.240 |
Why?
| | Risk | 2 | 2018 | 854 | 0.240 |
Why?
| | Limit of Detection | 3 | 2012 | 55 | 0.240 |
Why?
| | Crotalus | 1 | 2004 | 18 | 0.240 |
Why?
| | Animal Experimentation | 1 | 2003 | 6 | 0.230 |
Why?
| | Mycophenolic Acid | 1 | 2004 | 79 | 0.230 |
Why?
| | Neck Injuries | 1 | 2023 | 20 | 0.230 |
Why?
| | Glasgow Coma Scale | 1 | 2004 | 150 | 0.230 |
Why?
| | Shock, Traumatic | 1 | 2023 | 18 | 0.230 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2436 | 0.230 |
Why?
| | Staphylococcus aureus | 1 | 2006 | 394 | 0.220 |
Why?
| | Ventilators, Mechanical | 1 | 2023 | 47 | 0.220 |
Why?
| | Plant Extracts | 1 | 2004 | 165 | 0.220 |
Why?
| | Staphylococcal Infections | 1 | 2006 | 346 | 0.210 |
Why?
| | Feasibility Studies | 2 | 2023 | 749 | 0.210 |
Why?
| | Follow-Up Studies | 5 | 2017 | 4596 | 0.210 |
Why?
| | Toxicokinetics | 2 | 2018 | 9 | 0.200 |
Why?
| | Consensus | 3 | 2021 | 534 | 0.200 |
Why?
| | Memory | 1 | 2023 | 230 | 0.200 |
Why?
| | Heart Rate | 3 | 2015 | 729 | 0.200 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 159 | 0.200 |
Why?
| | Soil Pollutants | 1 | 2020 | 14 | 0.200 |
Why?
| | Emergency Responders | 1 | 2021 | 34 | 0.200 |
Why?
| | Lactates | 2 | 2012 | 87 | 0.190 |
Why?
| | Personal Protective Equipment | 1 | 2021 | 50 | 0.190 |
Why?
| | Disulfides | 1 | 2020 | 91 | 0.190 |
Why?
| | Guidelines as Topic | 3 | 2017 | 262 | 0.190 |
Why?
| | Prescription Drug Monitoring Programs | 1 | 2020 | 11 | 0.190 |
Why?
| | Inhalation Exposure | 1 | 2020 | 87 | 0.190 |
Why?
| | Patient Outcome Assessment | 2 | 2021 | 122 | 0.180 |
Why?
| | Wounds, Nonpenetrating | 2 | 2021 | 285 | 0.180 |
Why?
| | Immunosuppressive Agents | 1 | 2004 | 681 | 0.180 |
Why?
| | Calcium | 2 | 2023 | 1171 | 0.170 |
Why?
| | Brain Injuries | 2 | 2023 | 484 | 0.170 |
Why?
| | Ketorolac | 1 | 2019 | 18 | 0.170 |
Why?
| | Models, Animal | 1 | 2021 | 363 | 0.170 |
Why?
| | Haloperidol | 1 | 2019 | 36 | 0.170 |
Why?
| | Agkistrodon | 1 | 2019 | 19 | 0.170 |
Why?
| | Gases | 1 | 2019 | 46 | 0.170 |
Why?
| | Adrenergic Agonists | 1 | 2018 | 5 | 0.170 |
Why?
| | Harm Reduction | 1 | 2019 | 25 | 0.170 |
Why?
| | Sodium Cyanide | 1 | 2018 | 1 | 0.170 |
Why?
| | Blood Circulation | 1 | 2018 | 36 | 0.170 |
Why?
| | Terrorism | 1 | 2018 | 25 | 0.170 |
Why?
| | Documentation | 1 | 2020 | 175 | 0.170 |
Why?
| | Pyruvate Dehydrogenase Complex | 1 | 2018 | 8 | 0.170 |
Why?
| | Reproducibility of Results | 3 | 2013 | 2874 | 0.160 |
Why?
| | Biomarkers | 3 | 2019 | 3588 | 0.160 |
Why?
| | Saliva | 1 | 2019 | 188 | 0.160 |
Why?
| | Cholinesterase Inhibitors | 1 | 2018 | 26 | 0.160 |
Why?
| | Torso | 1 | 2018 | 30 | 0.160 |
Why?
| | War Exposure | 1 | 2018 | 11 | 0.160 |
Why?
| | Dextropropoxyphene | 1 | 2017 | 3 | 0.160 |
Why?
| | Vascular Access Devices | 1 | 2018 | 24 | 0.160 |
Why?
| | Tramadol | 1 | 2017 | 11 | 0.160 |
Why?
| | Burns, Inhalation | 1 | 2017 | 9 | 0.160 |
Why?
| | Methemoglobinemia | 1 | 2017 | 13 | 0.160 |
Why?
| | Tidal Volume | 1 | 2018 | 74 | 0.160 |
Why?
| | Drug Prescriptions | 2 | 2020 | 248 | 0.150 |
Why?
| | Solid Phase Extraction | 2 | 2019 | 19 | 0.150 |
Why?
| | Blood Proteins | 1 | 2019 | 248 | 0.150 |
Why?
| | Analysis of Variance | 2 | 2017 | 1295 | 0.150 |
Why?
| | Rescue Work | 1 | 2017 | 8 | 0.150 |
Why?
| | Acidosis | 2 | 2009 | 86 | 0.150 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2015 | 366 | 0.150 |
Why?
| | Blood Component Transfusion | 1 | 2018 | 84 | 0.150 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 403 | 0.150 |
Why?
| | Hemoglobins | 2 | 2018 | 326 | 0.150 |
Why?
| | Disease Management | 3 | 2017 | 571 | 0.150 |
Why?
| | Blood Coagulation | 1 | 2018 | 219 | 0.150 |
Why?
| | Epidemics | 1 | 2018 | 70 | 0.150 |
Why?
| | Shock, Septic | 1 | 2019 | 187 | 0.150 |
Why?
| | Dextromethorphan | 1 | 2016 | 19 | 0.150 |
Why?
| | Inpatients | 1 | 2020 | 389 | 0.150 |
Why?
| | Headache | 1 | 2017 | 128 | 0.150 |
Why?
| | Burns, Chemical | 1 | 2017 | 25 | 0.150 |
Why?
| | Antacids | 1 | 2016 | 15 | 0.150 |
Why?
| | Telephone | 1 | 2017 | 152 | 0.140 |
Why?
| | Musculoskeletal Diseases | 1 | 2017 | 68 | 0.140 |
Why?
| | Educational Status | 2 | 2016 | 437 | 0.140 |
Why?
| | Medical Errors | 1 | 2017 | 89 | 0.140 |
Why?
| | Sodium Chloride | 1 | 2017 | 144 | 0.140 |
Why?
| | Pharmacy Service, Hospital | 1 | 2017 | 86 | 0.140 |
Why?
| | Clinical Protocols | 1 | 2018 | 238 | 0.140 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 304 | 0.140 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1167 | 0.140 |
Why?
| | Decision Trees | 1 | 2016 | 83 | 0.140 |
Why?
| | Algorithms | 2 | 2016 | 1541 | 0.140 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2016 | 83 | 0.140 |
Why?
| | Prognosis | 2 | 2019 | 3443 | 0.140 |
Why?
| | Point-of-Care Testing | 1 | 2016 | 31 | 0.140 |
Why?
| | Brain Concussion | 1 | 2023 | 470 | 0.140 |
Why?
| | Proteome | 1 | 2019 | 353 | 0.140 |
Why?
| | Massachusetts | 1 | 2016 | 141 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2023 | 1244 | 0.140 |
Why?
| | Prescription Drug Diversion | 1 | 2015 | 12 | 0.140 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 187 | 0.140 |
Why?
| | Heart Diseases | 1 | 2019 | 341 | 0.140 |
Why?
| | Benzodiazepines | 1 | 2016 | 122 | 0.140 |
Why?
| | Breast Neoplasms | 1 | 2007 | 1965 | 0.130 |
Why?
| | Sepsis | 1 | 2021 | 531 | 0.130 |
Why?
| | Radiation Injuries | 1 | 2017 | 131 | 0.130 |
Why?
| | Drug Costs | 1 | 2016 | 94 | 0.130 |
Why?
| | Zebrafish Proteins | 1 | 2018 | 254 | 0.130 |
Why?
| | Disaster Planning | 1 | 2016 | 76 | 0.130 |
Why?
| | Cross-Sectional Studies | 2 | 2016 | 4552 | 0.130 |
Why?
| | Methotrexate | 1 | 2016 | 227 | 0.130 |
Why?
| | Drug Utilization Review | 1 | 2015 | 60 | 0.130 |
Why?
| | Angiography | 2 | 2013 | 185 | 0.130 |
Why?
| | Phenols | 1 | 2015 | 85 | 0.130 |
Why?
| | Metabolome | 1 | 2018 | 296 | 0.130 |
Why?
| | Clinical Competence | 2 | 2014 | 951 | 0.130 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1125 | 0.130 |
Why?
| | Practice Patterns, Nurses' | 1 | 2014 | 15 | 0.130 |
Why?
| | Vitamin B Complex | 1 | 2014 | 37 | 0.120 |
Why?
| | Nurses | 1 | 2016 | 142 | 0.120 |
Why?
| | Length of Stay | 2 | 2016 | 1031 | 0.120 |
Why?
| | Logistic Models | 2 | 2017 | 1901 | 0.120 |
Why?
| | Anesthesia, General | 1 | 2014 | 48 | 0.120 |
Why?
| | Thyroid Cartilage | 1 | 2014 | 5 | 0.120 |
Why?
| | Teaching Rounds | 1 | 2015 | 59 | 0.120 |
Why?
| | Societies, Medical | 1 | 2018 | 703 | 0.120 |
Why?
| | Anesthetics | 1 | 2014 | 58 | 0.120 |
Why?
| | Aged, 80 and over | 3 | 2016 | 6561 | 0.120 |
Why?
| | Mortality | 1 | 2016 | 299 | 0.120 |
Why?
| | Shock | 2 | 2012 | 92 | 0.120 |
Why?
| | Aspartate Aminotransferases | 1 | 2014 | 95 | 0.120 |
Why?
| | Liver Function Tests | 1 | 2014 | 107 | 0.120 |
Why?
| | Mentors | 1 | 2015 | 166 | 0.120 |
Why?
| | Health Services Research | 1 | 2016 | 385 | 0.120 |
Why?
| | Ketoglutaric Acids | 1 | 2013 | 16 | 0.120 |
Why?
| | Proteomics | 1 | 2019 | 876 | 0.120 |
Why?
| | Thiazoles | 1 | 2014 | 121 | 0.120 |
Why?
| | Alanine Transaminase | 1 | 2014 | 152 | 0.120 |
Why?
| | Central Nervous System Stimulants | 1 | 2015 | 142 | 0.120 |
Why?
| | Academic Medical Centers | 1 | 2016 | 422 | 0.110 |
Why?
| | Ischemia | 2 | 2014 | 374 | 0.110 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 245 | 0.110 |
Why?
| | Necrosis | 1 | 2014 | 230 | 0.110 |
Why?
| | Metabolomics | 1 | 2018 | 550 | 0.110 |
Why?
| | Drug Combinations | 1 | 2014 | 291 | 0.110 |
Why?
| | Health Surveys | 1 | 2015 | 454 | 0.110 |
Why?
| | Common Cold | 1 | 2012 | 11 | 0.110 |
Why?
| | Tertiary Healthcare | 1 | 2012 | 28 | 0.110 |
Why?
| | Nitriles | 1 | 2013 | 155 | 0.110 |
Why?
| | Drug Stability | 1 | 2013 | 153 | 0.110 |
Why?
| | Data Collection | 1 | 2015 | 658 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 1947 | 0.110 |
Why?
| | Respiratory System Agents | 1 | 2012 | 22 | 0.110 |
Why?
| | Cues | 1 | 2014 | 297 | 0.110 |
Why?
| | Chromatography, Thin Layer | 1 | 2012 | 23 | 0.110 |
Why?
| | Basilar Artery | 1 | 2012 | 7 | 0.110 |
Why?
| | Safety | 2 | 2013 | 304 | 0.110 |
Why?
| | Blood Chemical Analysis | 1 | 2012 | 95 | 0.100 |
Why?
| | Cough | 1 | 2012 | 102 | 0.100 |
Why?
| | Nonprescription Drugs | 1 | 2012 | 67 | 0.100 |
Why?
| | Triage | 2 | 2017 | 203 | 0.100 |
Why?
| | Fever | 1 | 2013 | 283 | 0.100 |
Why?
| | Risk Assessment | 2 | 2018 | 3057 | 0.100 |
Why?
| | Femur | 1 | 2013 | 199 | 0.100 |
Why?
| | Aged | 6 | 2019 | 19657 | 0.100 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 74 | 0.100 |
Why?
| | Abbreviated Injury Scale | 2 | 2021 | 21 | 0.100 |
Why?
| | Pain, Postoperative | 1 | 2012 | 210 | 0.100 |
Why?
| | Patient Satisfaction | 1 | 2015 | 610 | 0.100 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 536 | 0.090 |
Why?
| | Mice | 4 | 2023 | 15520 | 0.090 |
Why?
| | Needlestick Injuries | 1 | 2010 | 4 | 0.090 |
Why?
| | Drug Administration Routes | 1 | 2010 | 42 | 0.090 |
Why?
| | Health Care Surveys | 1 | 2012 | 546 | 0.090 |
Why?
| | Sleep Stages | 1 | 2010 | 60 | 0.090 |
Why?
| | Nausea | 1 | 2010 | 107 | 0.090 |
Why?
| | Tissue Plasminogen Activator | 1 | 2012 | 230 | 0.090 |
Why?
| | Vomiting | 1 | 2010 | 123 | 0.090 |
Why?
| | Tympanic Membrane Perforation | 1 | 2009 | 13 | 0.090 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 237 | 0.090 |
Why?
| | Mental Health | 1 | 2015 | 568 | 0.090 |
Why?
| | Manikins | 1 | 2009 | 26 | 0.090 |
Why?
| | Curriculum | 1 | 2015 | 910 | 0.080 |
Why?
| | Allied Health Personnel | 1 | 2009 | 44 | 0.080 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2017 | 765 | 0.080 |
Why?
| | Patient Care Team | 1 | 2013 | 521 | 0.080 |
Why?
| | Electronic Health Records | 1 | 2015 | 829 | 0.080 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1795 | 0.080 |
Why?
| | Decision Support Systems, Clinical | 2 | 2021 | 178 | 0.080 |
Why?
| | Inservice Training | 1 | 2009 | 106 | 0.080 |
Why?
| | Arrhythmias, Cardiac | 1 | 2010 | 277 | 0.080 |
Why?
| | Thoracostomy | 1 | 2007 | 18 | 0.080 |
Why?
| | Anaphylaxis | 1 | 2010 | 146 | 0.080 |
Why?
| | Risk Factors | 5 | 2017 | 9001 | 0.080 |
Why?
| | Primary Health Care | 2 | 2020 | 1560 | 0.080 |
Why?
| | Spectrum Analysis | 2 | 2018 | 88 | 0.070 |
Why?
| | Decision Support Techniques | 1 | 2011 | 364 | 0.070 |
Why?
| | Equipment Design | 1 | 2009 | 519 | 0.070 |
Why?
| | Fatal Outcome | 1 | 2007 | 287 | 0.070 |
Why?
| | Sodium Channels | 1 | 2007 | 63 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2674 | 0.070 |
Why?
| | Oxygen Consumption | 2 | 2019 | 586 | 0.070 |
Why?
| | Vasopressins | 1 | 2006 | 64 | 0.070 |
Why?
| | Health Services Accessibility | 1 | 2012 | 781 | 0.070 |
Why?
| | Atomoxetine Hydrochloride | 1 | 2005 | 4 | 0.070 |
Why?
| | Propylamines | 1 | 2005 | 12 | 0.070 |
Why?
| | Vasoconstrictor Agents | 1 | 2006 | 122 | 0.070 |
Why?
| | Death, Sudden | 1 | 2005 | 33 | 0.070 |
Why?
| | Valproic Acid | 1 | 2005 | 44 | 0.070 |
Why?
| | Treatment Failure | 1 | 2007 | 341 | 0.070 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2007 | 116 | 0.070 |
Why?
| | Vasospasm, Intracranial | 1 | 2005 | 18 | 0.070 |
Why?
| | Community-Acquired Infections | 1 | 2006 | 143 | 0.060 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2005 | 64 | 0.060 |
Why?
| | Dimethylformamide | 1 | 2004 | 1 | 0.060 |
Why?
| | Hexanones | 1 | 2004 | 1 | 0.060 |
Why?
| | Kerosene | 1 | 2004 | 1 | 0.060 |
Why?
| | Hexanes | 1 | 2004 | 3 | 0.060 |
Why?
| | Cyclohexenes | 1 | 2004 | 6 | 0.060 |
Why?
| | Administration, Inhalation | 1 | 2006 | 656 | 0.060 |
Why?
| | Alkanes | 1 | 2004 | 16 | 0.060 |
Why?
| | Oleic Acid | 1 | 2004 | 34 | 0.060 |
Why?
| | Dimethyl Sulfoxide | 1 | 2004 | 45 | 0.060 |
Why?
| | Linoleic Acid | 1 | 2004 | 41 | 0.060 |
Why?
| | Parents | 1 | 2012 | 1212 | 0.060 |
Why?
| | Charcoal | 1 | 2004 | 23 | 0.060 |
Why?
| | Blood Cell Count | 1 | 2004 | 53 | 0.060 |
Why?
| | Sorbitol | 1 | 2023 | 27 | 0.060 |
Why?
| | Anticonvulsants | 1 | 2005 | 184 | 0.060 |
Why?
| | Half-Life | 2 | 2014 | 147 | 0.060 |
Why?
| | Lupus Nephritis | 1 | 2004 | 55 | 0.060 |
Why?
| | Fibrin | 1 | 2004 | 60 | 0.060 |
Why?
| | Rats | 2 | 2022 | 5394 | 0.060 |
Why?
| | Observer Variation | 1 | 2004 | 309 | 0.060 |
Why?
| | Ambulances | 1 | 2023 | 49 | 0.060 |
Why?
| | Fibrinogen | 1 | 2004 | 161 | 0.060 |
Why?
| | Video Recording | 1 | 2023 | 156 | 0.060 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2019 | 490 | 0.060 |
Why?
| | Hemostasis | 1 | 2023 | 70 | 0.060 |
Why?
| | Calcium, Dietary | 1 | 2023 | 55 | 0.050 |
Why?
| | Depressive Disorder | 1 | 2005 | 333 | 0.050 |
Why?
| | Intracranial Hemorrhages | 1 | 2023 | 77 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2023 | 164 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2022 | 48 | 0.050 |
Why?
| | Armed Conflicts | 1 | 2021 | 13 | 0.050 |
Why?
| | Bandages | 1 | 2021 | 31 | 0.050 |
Why?
| | Cricetulus | 1 | 2021 | 98 | 0.050 |
Why?
| | CHO Cells | 1 | 2021 | 143 | 0.050 |
Why?
| | Aviation | 1 | 2021 | 10 | 0.050 |
Why?
| | Fumigation | 1 | 2020 | 2 | 0.050 |
Why?
| | Sheep | 1 | 2004 | 764 | 0.050 |
Why?
| | Cricetinae | 1 | 2021 | 263 | 0.050 |
Why?
| | Hypertension | 1 | 2010 | 1203 | 0.050 |
Why?
| | Hydrazines | 1 | 2021 | 31 | 0.050 |
Why?
| | Oximetry | 1 | 2021 | 84 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2018 | 2478 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 253 | 0.050 |
Why?
| | Cadaver | 1 | 2022 | 327 | 0.050 |
Why?
| | Age Factors | 2 | 2019 | 2995 | 0.050 |
Why?
| | Hemolysis | 1 | 2022 | 174 | 0.050 |
Why?
| | Pesticides | 1 | 2020 | 47 | 0.050 |
Why?
| | Mammals | 1 | 2022 | 253 | 0.050 |
Why?
| | Intersectoral Collaboration | 1 | 2020 | 60 | 0.050 |
Why?
| | Quality Improvement | 2 | 2021 | 963 | 0.050 |
Why?
| | Myocardial Infarction | 1 | 2007 | 968 | 0.050 |
Why?
| | Plasma | 1 | 2022 | 224 | 0.050 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 171 | 0.040 |
Why?
| | Regression Analysis | 1 | 2021 | 984 | 0.040 |
Why?
| | Directive Counseling | 1 | 2019 | 42 | 0.040 |
Why?
| | Hypothermia | 1 | 2019 | 32 | 0.040 |
Why?
| | Hospitalization | 2 | 2019 | 1784 | 0.040 |
Why?
| | Cholinesterase Reactivators | 1 | 2018 | 1 | 0.040 |
Why?
| | Phosphorylation | 1 | 2023 | 1634 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2018 | 53 | 0.040 |
Why?
| | Organophosphate Poisoning | 1 | 2018 | 2 | 0.040 |
Why?
| | North America | 1 | 2019 | 266 | 0.040 |
Why?
| | Hippocampus | 1 | 2023 | 735 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2021 | 5255 | 0.040 |
Why?
| | Drug Storage | 1 | 2018 | 59 | 0.040 |
Why?
| | Resource Allocation | 1 | 2018 | 38 | 0.040 |
Why?
| | Catheterization, Peripheral | 1 | 2019 | 107 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2021 | 1474 | 0.040 |
Why?
| | Peptides | 1 | 2023 | 879 | 0.040 |
Why?
| | Multiple Trauma | 1 | 2018 | 97 | 0.040 |
Why?
| | Antipsychotic Agents | 1 | 2019 | 193 | 0.040 |
Why?
| | Chemical Warfare Agents | 1 | 2018 | 103 | 0.040 |
Why?
| | Burn Units | 1 | 2016 | 26 | 0.040 |
Why?
| | United States Department of Veterans Affairs | 1 | 2020 | 555 | 0.040 |
Why?
| | Carbon Dioxide | 1 | 2018 | 230 | 0.040 |
Why?
| | Qualitative Research | 1 | 2020 | 953 | 0.030 |
Why?
| | Advisory Committees | 1 | 2016 | 212 | 0.030 |
Why?
| | Disasters | 1 | 2016 | 89 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2018 | 940 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2020 | 699 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 161 | 0.030 |
Why?
| | Hypoxia | 1 | 2021 | 963 | 0.030 |
Why?
| | Neurons | 1 | 2023 | 1345 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1868 | 0.030 |
Why?
| | Recovery of Function | 1 | 2018 | 604 | 0.030 |
Why?
| | Inactivation, Metabolic | 1 | 2014 | 10 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2014 | 139 | 0.030 |
Why?
| | Drug Approval | 1 | 2014 | 77 | 0.030 |
Why?
| | Eating | 1 | 2016 | 369 | 0.030 |
Why?
| | Thiazolidines | 1 | 2013 | 7 | 0.030 |
Why?
| | Pharmacokinetics | 1 | 2013 | 27 | 0.030 |
Why?
| | Indicators and Reagents | 1 | 2013 | 100 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 2013 | 43 | 0.030 |
Why?
| | Drug Monitoring | 1 | 2014 | 187 | 0.030 |
Why?
| | Critical Care Nursing | 1 | 2013 | 31 | 0.030 |
Why?
| | Species Specificity | 1 | 2014 | 565 | 0.030 |
Why?
| | Traumatology | 1 | 2012 | 24 | 0.030 |
Why?
| | Teaching | 1 | 2015 | 236 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1129 | 0.030 |
Why?
| | Educational Measurement | 1 | 2015 | 289 | 0.030 |
Why?
| | Quality Control | 1 | 2012 | 159 | 0.030 |
Why?
| | Infusions, Intra-Arterial | 1 | 2012 | 46 | 0.030 |
Why?
| | Arginine | 1 | 2013 | 249 | 0.030 |
Why?
| | Arterial Pressure | 1 | 2012 | 99 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2019 | 3171 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2012 | 175 | 0.030 |
Why?
| | Organizational Innovation | 1 | 2012 | 138 | 0.030 |
Why?
| | Erythrocytes | 1 | 2016 | 641 | 0.020 |
Why?
| | Acute Coronary Syndrome | 1 | 2014 | 257 | 0.020 |
Why?
| | Delphi Technique | 1 | 2011 | 164 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2566 | 0.020 |
Why?
| | Fingers | 1 | 2010 | 83 | 0.020 |
Why?
| | Explosive Agents | 1 | 2009 | 9 | 0.020 |
Why?
| | Thrombosis | 1 | 2013 | 309 | 0.020 |
Why?
| | Injections | 1 | 2010 | 167 | 0.020 |
Why?
| | Comorbidity | 1 | 2013 | 1526 | 0.020 |
Why?
| | Vasodilator Agents | 1 | 2010 | 328 | 0.020 |
Why?
| | Pulse | 1 | 2006 | 27 | 0.020 |
Why?
| | Immunoassay | 1 | 2007 | 101 | 0.020 |
Why?
| | Coronary Circulation | 1 | 2006 | 121 | 0.020 |
Why?
| | Electric Countershock | 1 | 2006 | 110 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2007 | 230 | 0.020 |
Why?
| | Delivery of Health Care | 1 | 2012 | 867 | 0.020 |
Why?
| | Haplorhini | 1 | 2005 | 62 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2013 | 2235 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3174 | 0.010 |
Why?
|
|
Bebarta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|